Journal of Pharmaceutical and Biomedical Analysis 2012-01-01

Development and validation of reversed phase high performance liquid chromatographic method for determination of moxonidine in the presence of its impurities

Svetlana Milovanović, Biljana Otašević, Mira Zečević, Ljiljana Živanović, Ana Protić, Svetlana Milovanović, Biljana Otašević, Mira Zečević, Ljiljana Živanović, Ana Protić

Index: J. Pharm. Biomed. Anal. 59 , 151-6, (2012)

Full Text: HTML

Abstract

Highlights ► Moxonidine is a second-generation centrally acting antihypertensive drug. ► An isocratic RP–HPLC method was developed for the analysis of moxonidine and its impurities. ► Central composite design and response surface methodology were used as statistical tools. ► Statistical tools were applied in method development and robustness testing.

Related Compounds

  • Moxonidine

Related Articles:

Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?

2004-03-01

[Curr. Med. Res. Opin. 20(3) , 359-67, (2004)]

Moxonidine: a review of safety and tolerability after seven years of clinical experience.

1999-08-01

[J. Hypertens. 17 , S37-S39, (1999)]

[The efficacy of antihypertension drugs and their combinations in the non-treated hypertension].

2013-01-01

[Med. Tr. Prom. Ekol. (5) , 7-11, (2013)]

The protective effects of metyrosine, lacidipine, clonidine, and moxonidine on kidney damage induced by unilateral ureteral obstruction in rats.

2012-11-01

[Surg. Today 42(11) , 1051-60, (2012)]

Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.

2013-09-01

[Am. J. Cardiol. 112(5) , 684-7, (2013)]

More Articles...